This is an online version of our new Markets A.M. newsletter by Spencer Jakab. Get investing insights in your inbox each weekday by signing up here—it’s free. 📧 Tomorrow, two U.S. Treasury notes will ...
About This EventNovocure (Nasdaq: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, ...